Nektar Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Nektar Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Nektar Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Nektar Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $536k | 574k | 0.93 |
| 2023-12-31 | $281k | 497k | 0.57 |
| 2023-09-30 | $293k | 492k | 0.60 |
| 2023-06-30 | $365k | 635k | 0.58 |
| 2023-03-31 | $315k | 448k | 0.70 |
| 2022-12-31 | $365k | 161k | 2.26 |
| 2022-09-30 | $34k | 11k | 3.17 |
| 2022-06-30 | $144k | 38k | 3.81 |
| 2022-03-31 | $908k | 169k | 5.39 |
| 2021-12-31 | $717k | 53k | 13.50 |
| 2021-06-30 | $270k | 16k | 17.16 |
| 2019-12-31 | $554k | 26k | 21.58 |
| 2014-03-31 | $171k | 13k | 13.36 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management